...more data to confirm the Ruyan findings
For validation of Ruyan teams reported results, I expect that well hear something similar from another team, soon. Maybe its not by chance that we first have read about a blood nicotine study in a [thread=11758]Washington Post article[/thread], where a visit at the American Legacy Foundation has been reported
(e.g. see ALFs position on ecigs here). And its probably not lacking factual grounds that ALF president Dr. Cheryl Healton did actually state that ecigs deliver less nicotine [thread=16240] (in a recent NBC news feature)[/thread]. Just as it could read between the lines of the [thread=11758]Washington Post article[/thread], already.
Cant say its all placebo, because there is some physiological effect (variable for different users habit, devices, fluid, and so on). However, something really appears to be missing to a large extent. Im curious to read about possible explanations that medical folk may come up with.
... argue their way out of regulation in the US.
Now, the vocal tobacco control / US public health policy community follows a clear cut mantra: allowing for two slots only, there are cigarettes and there are FDA regulated pharmaceutical nicotine products to help patients off of cigarettes. Within thus fixed framework, ecigs do have no place to even be considered on the market - if they are not effective. A measure of effectiveness may be blood nicotine levels. Assuming a group comes fast to confirm low effectiveness, this would be crafted into a policy weapon against ecigs (and focusing on it could push aside anecdotal user testimonials).
Catch22?
Yes, virtually ecig prohibition, if regulators (FDA) would indeed adopt the position of some vocal US public health pressure groups.
No, leaving ecigs on the market, if regulators follow a common-sense approach (as usually in place for other consumer products).